Opportunity overview
North West London Pathology (NWLP) – a partnership between Imperial College Healthcare NHS Trust, Chelsea and Westminster NHS Foundation Trust, and The Hillingdon Hospital NHS Foundation Trust – is initiating this Pre-Market Engagement (PME) to inform a potential procurement. NWLP’s current laboratory hub space is poorly configured and not able to accommodate expected volume growth. NWLP is therefore seeking to engage with suppliers to inform a new kind of contracting model that could deliver an integrated, combined service. NWLP is considering an Infrastructure-as-a-Service (IaaS) arrangement. Due to the fact that NWLP does not have access to a significant capital budget, a primary objective is to develop an off-balance-sheet solution for both premises and laboratory equipment. NWLP is also keen to develop a partnership which can support future growth, innovation, research and efficiency. Key features of the commercial framework being explored include: Volume-Based Pricing: An entirely volume-based pricing approach (price-per-request) covering equipment, building, and maintenance costs. Risk and Reward Sharing: A partner to help NWLP expand and win new business while sharing the frustrations of recommissioning decisions. Proposed Duration: An initial operational term anticipated to be 14 years, with the potential for two 7-year extensions at the option of NWLP. The contract would likely encompass a comprehensive range of requirements, including: Provision of Premises: Securing, fitting out, and managing a hub facility that allows NWLP to participate in the local life sciences community. Laboratory Equipment: Provision of kit, including internal software, maintenance, and lifecycle replacement. Facilities Management: Hard FM, building lifecycle, and utilities. Ancillary Services: Potential inclusion of consumables, Soft FM, and LIMS/software interfaces. NWLP welcomes feedback from a broad range of market participants, including equipment suppliers, landlords, property investors, and potential service integrators. We are seeking frank and comprehensive feedback to help frame the requirement as constructively as possible while respecting the financial constraints we face. Note on SMEs: NWLP aims to reduce barriers for Small and Medium-sized Enterprises. SMEs are encouraged to seek opportunities to participate by joining the supply chains of larger equipment providers or service teams to contribute to the overall solution. Suppliers who are interested in this opportunity should complete the attached questionnaire and respond back by July 16th 2026. To access the opportunity, please use Atamis via contract reference C454074. https://atamis-1928--prospend.vf.force.com/apex/CS_ContractPage?filters=&page=1&Preview=Yes&searchStr=&SearchType=Projects&sortStr=Alphabetical&uid=a07Pz00001gu7CeIAI&sfdcIFrameOrigin=https%3A%2F%2Fatamis-1928.lightning.force.com
Classification
- CPV33124100 — Diagnostic devices
- CPV33124110 — Diagnostic systems
- CPV33124130 — Diagnostic supplies
- CPV33124131 — Reagent strips
- CPV33140000 — Medical consumables
- CPV33694000 — Diagnostic agents
- CPV33696000 — Reagents and contrast media
- CPV33696200 — Blood-testing reagents
- CPV38432000 — Analysis apparatus
- CPV38434000 — Analysers
- CPV38434560 — Chemistry analyser
- CPV45400000 — Building completion work
- CPV50700000 — Repair and maintenance services of building installations
- CPV70310000 — Building rental or sale services
- CPV85111800 — Pathology services
Lots
- Lot 1Value not stated
Documents and notices
- Preliminary market engagement notice on Find a TenderOpen source ↗